资讯
Do you know someone who would make a good ASCO President, Board member, or Nominating Committee member? In advance of the upcoming election, the ASCO Nominating Committee is seeking recommendations ...
The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...
The TEC Lounge hosts activities designed to help attendees make the most of their Annual Meeting experience, connect with peers, explore career and research options in oncology, and network with ...
“This trial emphasizes the importance of germline and somatic testing in patients with metastatic prostate cancer at the time of diagnosis; homologous recombination repair mutations have been ...
ASCO’s patient education resources are reviewed by ASCO’s Patient Information Editorial Board, composed of 200+ medical, surgical, radiation, and pediatric oncologists; multidisciplinary members of ...
“This early but promising observational study suggests a powerful synergy: patients with stage III colon cancer who embraced anti-inflammatory foods and exercised regularly showed the best overall ...
“This is the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer to demonstrate that post-treatment exercise is both achievable and effective in improving ...
We want you to have the best meeting experience possible. To help you navigate the meeting and engage with presenters and content, we have prepared the below overview ...
The 2025 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Robin Zon's Presidential theme, Driving Knowledge to Action: Building a Better Future. View the Sessions At A ...
The ASCO-Sponsored Patient Advocacy Booth at the ASCO Annual Meeting provides complimentary exhibit space where not-for-profit patient advocacy organizations may promote their programs, services, and ...
An internationally recognized oncology leader and health care executive, Dr. Knudsen is the CEO of the Parker Institute for Cancer Immunotherapy. Dr. Knudsen was previously CEO of the American Cancer ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果